Insider Transactions in Q3 2025 at Acadia Pharmaceuticals Inc (ACAD)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2025
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,498
-7.45%
|
$80,454
$23.65 P/Share
|
|
Sep 12
2025
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,815
+12.68%
|
-
|
|
Sep 02
2025
|
Elizabeth A. Garofalo |
SELL
Open market or private sale
|
Direct |
1,600
-5.93%
|
$40,000
$25.98 P/Share
|
|
Aug 18
2025
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
22,000
-35.41%
|
$550,000
$25.18 P/Share
|